Company intelligence / Profile preview

Alivus Life Sciences

Mumbai, Maharashtra, Indiaalivus.com ↗

Ownership: Public · ALIVUS
Employees: ~2014
Development stage: Other

Overview

Alivus Life Sciences has a strong portfolio of over 26 high-potency API products with nine validated for commercialization, three in advanced development, and 14 in laboratory development. The company supplies more than 180 APIs globally, with strong market growth and financial performance, serving chronic and specialty therapeutic areas. Recent financial guidance and reporting indicate continued expansion, margin stability, and ongoing investments in capacity and pipeline enrichment.

Therapeutic areas: EndocrinologyInfectious DiseasesGastroenterologyDermatologyCardiovascularOtherNeurology
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

Multiple global pharmaceutical clients

Financials

Market cap: $1.9B
Total revenue: $271.9M
Enterprise value: $1.8B

Beyond the preview

Go deeper on Alivus Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Alivus Life Sciences.